Trevi Therapeutics, Inc. (TRVI)

Trevi Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	910	368	86	116	20	44
Market Cap Growth	210.50%	330.28%	-26.01%	472.04%	-54.55%	-33.49%
Enterprise Value	702	304	-2	1	6	5
Last Close Price	7.60	4.12	1.34	1.93	0.78	2.42
PB Ratio	4.66	3.70	1.04	1.08	1.18	1.63
P/TBV Ratio	4.56	3.70	1.04	1.08	1.18	1.63
Debt / Equity Ratio	0.00	0.01	0.02	0.09	0.86	0.52
Quick Ratio	22.15	10.29	14.33	8.99	2.90	8.10
Current Ratio	22.43	10.41	15.03	9.15	2.98	8.33
Return on Equity (ROE)	-35.74%	-52.59%	-30.59%	-46.82%	-153.03%	-80.07%
Return on Assets (ROA)	-22.82%	-32.15%	-19.96%	-23.15%	-47.42%	-37.91%
Return on Capital (ROIC)	-24.14%	-34.90%	-21.15%	-25.18%	-55.37%	-42.13%
Earnings Yield	-5.23%	-13.01%	-33.97%	-25.21%	-167.88%	-73.64%
FCF Yield	-4.72%	-10.40%	-37.22%	-24.50%	-143.18%	-65.27%
Buyback Yield / Dilution	-14.02%	-2.97%	-53.44%	-182.56%	-26.48%	-53.88%

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q